SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease and still continues to have the worst prognosis of all gastrointestinal malignancies. Reports have demonstrated that secretory leukocyte protease inhibitor (SLPI) is overexpressed in various cancers and may be a potential t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Yao, Jian-Long, Dong, Shan-Chao, Hou, Feng-Qiang, Shi, He-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423143/
https://www.ncbi.nlm.nih.gov/pubmed/25954138
http://dx.doi.org/10.1186/s12935-015-0182-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423143/
https://www.ncbi.nlm.nih.gov/pubmed/25954138
http://dx.doi.org/10.1186/s12935-015-0182-4

Ejemplares similares